Biotech Startup Claims Path to Living to 150 Years

A Chinese biotech startup, Lonvi Biosciences, has ignited excitement in the scientific community by suggesting that humans could live up to 150 years. This bold claim is backed by a study published in the prestigious journal Nature Metabolism. According to the company’s chief technological officer, achieving this extraordinary lifespan may soon be a reality with the aid of a new supplement called Procyanidin C1 Senolytic Complex 1 (PCC1).

PCC1, crafted from grape seed extract, is categorized as a “senotherapeutic” or “senolytic.” The supplement reportedly works by targeting and eliminating senescent cells, often referred to as “zombie cells.” These cells accumulate as we age, halting reproduction while secreting harmful inflammatory compounds that contribute to tissue damage and various age-related diseases. The promise of PCC1 lies in its potential to extend longevity by ridding the body of these detrimental cells.

Despite the optimism surrounding PCC1, its efficacy remains unproven in humans. Current evidence is primarily derived from animal studies, specifically mice, which raises significant questions about its application to human biology. While mice studies show positive results, the jump from animal trials to human application is fraught with uncertainties. The notion of a supplement that could help humans live to 150 years is compelling but still speculative at this stage.

The history of anti-aging elixirs is littered with failed attempts and misguided beliefs. Ancient Chinese emperors sought eternal life through mercury pills, while Romans believed that the blood of fallen gladiators could restore youth. Such historical follies highlight the challenges of pursuing longevity through unverified methods. The case of Qin Shi Huang, who died at the age of 49 from mercury consumption, serves as a cautionary tale in the quest for immortality.

The scientific community has witnessed various experiments over the centuries, including the bizarre practices of the late 19th and early 20th centuries. Neurologist Charles Brown-Sequard gained notoriety for injecting himself with testicle extracts from animals, claiming enhanced vigor and mental clarity. Such claims, though likely fueled by the placebo effect, did initiate modern discussions around testosterone therapy. Surgeon Serge Voronoff took these ideas further by grafting monkey testicles onto aging men, yet the expected benefits were not realized.

In recent years, a multitude of vitamin and antioxidant supplements have emerged, each claiming to extend human life. Yet, none have demonstrated convincing results in rigorous clinical trials. Some pharmaceuticals, such as metformin, an established diabetes medication, and resveratrol, an antioxidant found in grapes, show promise based on preliminary studies. Still, marketers often promote these products prematurely, extrapolating animal data to human contexts without substantial evidence.

So, what does science currently endorse as effective for longevity? The answer is straightforward. Regular exercise combined with a balanced, mostly plant-based diet—approximately 1-1.2 grams of protein per kilogram of body weight—has well-documented benefits for health and longevity. Additionally, studies have indicated that caloric restriction can enhance lifespan in various animal models, including mice and chimpanzees.

The CALERIE trial (Comprehensive Assessment of Long-term Effect of Reducing Intake of Energy) explored the effects of calorie restriction on humans. The trial aimed to reduce caloric intake for around 200 non-obese participants over two years. Although participants managed to cut their intake by only 12 percent—far short of the targeted 25 percent—researchers conducted various biological aging tests.

While the CALERIE trial did not find a significant impact on the length of telomeres, the study did reveal that calorie restriction might slow down aging by two to three percent, effectively adding several years to life. This finding is comparable to the health benefits of quitting smoking.

Ultimately, the quest for the elusive Fountain of Youth continues, with the age-old advice of eating less and exercising more holding true. As for Lonvi Biosciences, the scientific community awaits the results of their ongoing human trials for PCC1, hoping that this new approach may shed light on the future of longevity research.

For now, the journey toward significantly extending human lifespan remains an intriguing yet complex endeavor, deeply rooted in both science and history.